Literature DB >> 7593111

Short-term complications of the lateral approach for non-constrained elbow replacement. Follow-up of 50 rheumatoid elbows.

P Ljung1, K Jonsson, U Rydholm.   

Abstract

We reviewed 50 capitellocondylar elbow replacements performed by the lateral approach in 42 rheumatoid patients, at a median follow-up of three years. There were two major and 17 minor complications; 18 were early and one was late. Eight elbows required reoperation: soft-tissue surgery was performed in seven and prosthesis removal in one because of a deep infection. There were few problems of instability, but one patient sustained a traumatic dislocation which was stabilised after ligament reconstruction. Wound healing was delayed in two of five elbows which had been immobilised postoperatively for only five days, but healing was rapid in 45 elbows immobilised for 12 days. There was transient ulnar-nerve palsy postoperatively in 11 patients, with permanent palsy in three. All elbows were painfree or only slightly painful at follow-up; 49 were stable and 43 had a range of motion sufficient for activities of daily living. Radiological loosening of the humeral component was suspected in one asymptomatic elbow. The lateral approach is recommended for use with the capitellocondylar type of prosthesis in rheumatoid elbows with reasonably well-preserved bone stock.

Entities:  

Mesh:

Year:  1995        PMID: 7593111

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  3 in total

Review 1.  Triceps on approach for total elbow arthroplasty: worth preserving? A review of approaches for total elbow arthroplasty.

Authors:  Simon J Booker; Chris D Smith
Journal:  Shoulder Elbow       Date:  2016-12-13

Review 2.  [Differential arthroplasty and endoprosthesis indications in rheumatoid arthritis of the elbow joint].

Authors:  B F Morrey
Journal:  Orthopade       Date:  2003-11       Impact factor: 1.087

Review 3.  Systematic review of primary total elbow prostheses used for the rheumatoid elbow.

Authors:  J C T van der Lugt; P M Rozing
Journal:  Clin Rheumatol       Date:  2004-04-16       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.